Answers are grounded in this paper and cite their sources.
Machine learning models predict catalytic performance in propene hydroformylation, highlighting new ligands and conditions.
Here, we develop machine learning (ML) models to predict catalytic performance in rhodium-catalyzed propene hydroformylation and identify new ligands and reaction conditions for enhanced yield and selectivity. A curated dataset of 215 experimentally obtained data points involving [Rh(acac)(CO)₂] precatalyst and 49 phosphine ligands was used. Molecular, electronic, and reaction descriptors were constructed using cheminformatic representations and dimensionality reduction. Among several algorithms tested, XGBoost exhibited the best performance, achieving a root-mean-square error (RMSE) of 9.85% for iso-selectivity under leave-one-ligand-out cross-validation. Feature importance analysis revealed that ligand and solvent descriptors most strongly influence selectivity, whereas turnover number (TON) predictions were more challenging. A bootstrapped ensemble of XGBoost models integrated with a genetic algorithm enabled the exploration of vast ligand–condition space, yielding 58 candidate ligands predicted to achieve TON ≥ 330 and Iso(%) ≥ 70. This study demonstrates that interpretable ML models can complement mechanistic understanding and accelerate catalyst design for small-alkene hydroformylation.
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: